跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 561 条关于
“VT-1953”
全部
561
临床试验
244
药物
251
机构
5
资讯
61
去年
Vyome Therapeutics' VT-1953 Shows Promise in Phase 2 Trial for Malignant Fungating Wounds
10个月前
Vyome Holdings Reports Positive Phase 2 Results for VT-1953 in Malignant Fungating Wounds
去年
Vyome's VT-1953 Demonstrates Significant Efficacy in Phase 2 Trial for Malignant Fungating Wounds
9个月前
Vyome's VT-1953 Achieves Primary Endpoints in Phase 2 Trial for Malignant Fungating Wounds
7个月前
Vyome Seeks Orphan Drug Status for VT-1953 as Independent Analysis Values Asset at $1 Billion Post-Phase 3
去年
Adagio Medical Restructures Operations to Focus on Pivotal VT Cryoablation Trial
去年
Osteal Therapeutics' VT-X7 KIT Shows Promise in Treating Periprosthetic Joint Infections
去年
Osteal Therapeutics' VT-X7 KIT Demonstrates Positive Results in Periprosthetic Joint Infection Trial
3个月前
VT-EBV-N Shows 95% Durable Disease-Free Survival in EBV-Positive ENKTL: Phase II Data at EHA 2026
上个月
Processa Pharmaceuticals Acquires Vidya Therapeutics, Secures $200 Million Financing to Advance Next-Generation BTK Inhibitor VT-7208
第 1 页,共 7 页
上一页
下一页